Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Payables (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Payables for 5 consecutive years, with $1.5 million as the latest value for Q3 2020.

  • Quarterly Payables fell 94.98% to $1.5 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Sep 2020, down 94.98% year-over-year, with the annual reading at $6.3 million for FY2019, 85.46% up from the prior year.
  • Payables for Q3 2020 was $1.5 million at Forte Biosciences, down from $2.6 million in the prior quarter.
  • The five-year high for Payables was $30.1 million in Q3 2019, with the low at $1.5 million in Q2 2018.
  • Average Payables over 5 years is $7.5 million, with a median of $6.8 million recorded in 2019.
  • The sharpest move saw Payables soared 561.6% in 2019, then tumbled 94.98% in 2020.
  • Over 5 years, Payables stood at $8.9 million in 2016, then grew by 3.21% to $9.2 million in 2017, then plummeted by 62.8% to $3.4 million in 2018, then skyrocketed by 85.46% to $6.3 million in 2019, then crashed by 76.03% to $1.5 million in 2020.
  • According to Business Quant data, Payables over the past three periods came in at $1.5 million, $2.6 million, and $6.6 million for Q3 2020, Q2 2020, and Q1 2020 respectively.